Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Perlin

Showing results (31-40 of 284) with videos related to

Pageof 29
Sort By:
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Msphere|December 21, 2018
A Novel, Rapid, and Low-Volume Assay for Therapeutic Drug Monitoring of Posaconazole and Other Long-Chain Azole-Class Antifungal DrugsGregory R Wiedman, Yanan Zhao, David S Perlin
Antimicrobial Agents and Chemotherapy|May 26, 2006
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1Sergey V Balashov, Steven Park, David S Perlin
Msphere|April 16, 2025
Tolerance and heteroresistance to echinocandins in <i>Candida auris</i>: conceptual issues, clinical implications, and outstanding questionsErika Shor, David S Perlin, Dimitrios P Kontoyiannis
Frontiers in Cellular and Infection Microbiology|October 30, 2023
Reactive oxidant species induced by antifungal drugs: identity, origins, functions, and connection to stress-induced cell deathIrene Gonzalez-Jimenez, David S Perlin, Erika Shor
Antimicrobial Agents and Chemotherapy|March 9, 2011
Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albuminGuillermo Garcia-Effron, Steven Park, David S Perlin
Antimicrobial Agents and Chemotherapy|October 29, 2008
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpointsGuillermo Garcia-Effron, Steven Park, David S Perlin
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Virulence|March 31, 2012
Molecular mechanisms of cryptococcal meningitisTong-Bao Liu, David S Perlin, Chaoyang Xue
Antimicrobial Agents and Chemotherapy|October 9, 2019
Detection of <i>Candida auris</i> antifungal drug resistance markers directly from clinical skin swabsMilena Kordalewska, Annie Lee, Yanan Zhao, et al.
Pageof 29

Showing results (31-40 of 284) with videos related to

Sort By:
Pageof 29
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Msphere|December 21, 2018
A Novel, Rapid, and Low-Volume Assay for Therapeutic Drug Monitoring of Posaconazole and Other Long-Chain Azole-Class Antifungal DrugsGregory R Wiedman, Yanan Zhao, David S Perlin
Antimicrobial Agents and Chemotherapy|May 26, 2006
Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1Sergey V Balashov, Steven Park, David S Perlin
Msphere|April 16, 2025
Tolerance and heteroresistance to echinocandins in <i>Candida auris</i>: conceptual issues, clinical implications, and outstanding questionsErika Shor, David S Perlin, Dimitrios P Kontoyiannis
Frontiers in Cellular and Infection Microbiology|October 30, 2023
Reactive oxidant species induced by antifungal drugs: identity, origins, functions, and connection to stress-induced cell deathIrene Gonzalez-Jimenez, David S Perlin, Erika Shor
Antimicrobial Agents and Chemotherapy|March 9, 2011
Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albuminGuillermo Garcia-Effron, Steven Park, David S Perlin
Antimicrobial Agents and Chemotherapy|October 29, 2008
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpointsGuillermo Garcia-Effron, Steven Park, David S Perlin
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Virulence|March 31, 2012
Molecular mechanisms of cryptococcal meningitisTong-Bao Liu, David S Perlin, Chaoyang Xue
Antimicrobial Agents and Chemotherapy|October 9, 2019
Detection of <i>Candida auris</i> antifungal drug resistance markers directly from clinical skin swabsMilena Kordalewska, Annie Lee, Yanan Zhao, et al.
Pageof 29